Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) CFO James M. Frates sold 32,500 shares of the business’s stock in a transaction dated Tuesday, May 16th. The stock was sold at an average price of $26.94, for a total value of $875,550.00. Following the completion of the transaction, the chief financial officer now owns 55,676 shares […]
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) insider Patrick D. Yeramian sold 11,965 shares of the business’s stock in a transaction that occurred on Monday, May 15th. The stock was sold at an average price of $29.03, for a total value of $347,343.95. Following the transaction, the insider now directly owns 208,417 shares in the […]
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) insider Patrick D. Yeramian sold 49,579 shares of the business’s stock in a transaction that occurred on Monday, April 17th. The shares were sold at an average price of $30.54, for a total value of $1,514,142.66. Following the completion of the sale, the insider now owns 208,417 shares […]
Emerald Advisers LLC boosted its holdings in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) by 39.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 836,909 shares of the company’s stock after purchasing an additional 235,683 shares during the quarter. Amylyx Pharmaceuticals […]
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) major shareholder Morningside Venture Investment sold 29,048 shares of Amylyx Pharmaceuticals stock in a transaction that occurred on Wednesday, March 29th. The stock was sold at an average price of $30.45, for a total value of $884,511.60. Following the completion of the transaction, the insider now directly owns […]